An oncofetal and developmental perspective on testicular germ cell cancer

被引:48
|
作者
Rijlaarsdam, Martin A. [1 ]
Looijenga, Leendert H. J. [1 ]
机构
[1] Erasmus MC Univ Med Ctr Rotterdam, Dept Pathol, Rotterdam, Netherlands
关键词
Germ cell tumor pathogenesis; Onco-fetal signaling; Cell cycle control; Pluripotency; Chemotherapy sensitivity; CARCINOMA-IN-SITU; EMBRYONIC STEM-CELLS; GENOME-WIDE ASSOCIATION; KIT TYROSINE KINASE; TRANSCRIPTIONAL REGULATORY CIRCUITRY; TUMOR-SUPPRESSOR GENE; INACTIVE X-CHROMOSOME; C-KIT; DNA METHYLATION; MESSENGER-RNA;
D O I
10.1016/j.semcancer.2014.07.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Germ cell tumors (GCTs) represent a diverse group of tumors presumably originating from (early fetal) developing germ cells. Most frequent are the testicular germ cell cancers (TGCC). Overall, TGCC is the most frequent malignancy in Caucasian males (20-40 years) and remains an important cause of (treatment related) mortality in these young men. The strong association between the phenotype of TGCC stem cell components and their totipotent ancestor (fetal primordial germ cell or gonocyte) makes these tumors highly relevant from an onco-fetal point of view. This review subsequently discusses the evidence for the early embryonic origin of TGCCs, followed by an overview of the crucial association between TGCC pathogenesis, genetics, environmental exposure and the (fetal) testicular micro-environment (genvironment). This culminates in an evaluation of three genvironmentally modulated hallmarks of TGCC directly related to the oncofetal pathogenesis of TGCC: (1) maintenance of pluripotency, (2) cell cycle control/cisplatin sensitivity and (3) regulation of proliferation/migration/apoptosis by KIT-KITL mediated receptor tyrosine kinase signaling. Briefly, TGCC exhibit identifiable stem cell components (seminoma and embryonal carcinoma) and progenitors that show large and consistent similarities to primordial/embryonic germ cells, their presumed totipotent cells of origin. TGCC pathogenesis depends crucially on a complex interaction of genetic and (micro-)environmental, i.e. genvironmental risk factors that have only been partly elucidated despite significant effort. TGCC stem cell components also show a high degree of similarity with embryonic stem/germ cells (ES) in the regulation of pluripotency and cell cycle control, directly related to their exquisite sensitivity to DNA damaging agents (e.g. cisplatin). Of note, (ES.specific) micro-RNAs play a pivotal role in the crossover between cell cycle control, pluripotency and chemosensitivity. Moreover, multiple consistent observations reported TGCC to be associated with KIT-KITL mediated receptor tyrosine kinase signaling, a pathway crucially implicated in proliferation, migration and survival during embryogenesis including germ cell development. In conclusion, TGCCs are a fascinating model for onco-fetal developmental processes especially with regard to studying cell cycle control, pluripotency maintenance and KIT-KITL signaling. The knowledge presented here contributes to better understanding of the molecular characteristics of TGCC pathogenesis, translating to identification of at risk individuals and enhanced quality of care for TGCC patients (diagnosis, treatment and follow-up). (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:59 / 74
页数:16
相关论文
共 50 条
  • [31] CCAFU Recommendations 2013: Testicular germ cell cancer
    Durand, X.
    Rigaud, J.
    Avances, C.
    Camparo, P.
    Flechon, A.
    Murez, T.
    Sebe, P.
    Culine, S.
    Iborra, F.
    Mottet, N.
    Coloby, P.
    Soulie, M.
    PROGRES EN UROLOGIE, 2013, 24 : S145 - S160
  • [32] Management of germ cell testicular cancer with pulmonary metastases
    Schnorrer, M
    Ondrus, D
    Carsky, S
    Hornak, M
    Belan, V
    Kausitz, J
    Matoska, J
    NEOPLASMA, 1996, 43 (01) : 47 - 50
  • [33] Diagnosis and Treatment of Patients with Testicular Germ Cell Cancer
    Jörg T. Hartmann
    Lothar Kanz
    Carsten Bokemeyer
    Drugs, 1999, 58 : 257 - 281
  • [34] BILATERAL SYNCHRONOUS TESTICULAR GERM-CELL CANCER
    REDMOND, J
    SAMHA, MA
    CHARLES, RS
    VUKELJA, SJ
    FARAGHER, D
    TENGLIN, R
    REID, T
    DAWSON, N
    AUERBACH, H
    RICHTER, MP
    SOUTHERN MEDICAL JOURNAL, 1995, 88 (03) : 305 - 308
  • [35] Cancer stem cell in relapsed testicular germ cell cancer: embryonic or somatic?
    Mego, Michal
    INTERNATIONAL JOURNAL OF ANDROLOGY, 2006, 29 (06): : 627 - 627
  • [36] Cancer testis antigen expression in testicular germ cell tumors and in intratubular germ cell neoplasia
    Chen, Yao-Tseng
    MODERN PATHOLOGY, 2015, 28 (05) : 742 - 744
  • [37] PRENATAL AND NEONATAL RISK FACTORS FOR TESTICULAR GERM CELL CANCER
    van Gelder, M.
    van Veldhoven, C.
    Wijers, C.
    Aben, K.
    Roeleveld, N.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2011, 173 : S44 - S44
  • [38] HEMATOGENOUS METASTASIS OF NONSEMINOMATOUS GERM-CELL TESTICULAR CANCER
    WEEMS, WL
    UROLOGY, 1985, 26 (06) : 583 - 584
  • [39] Late toxicity after treatment for testicular germ cell cancer
    Jakob, A
    Kollmannsberger, C
    Kanz, L
    Bokemeyer, C
    UROLOGE-AUSGABE A, 1998, 37 (06): : 635 - 647
  • [40] Late toxicity after treatment for testicular germ cell cancer
    A. Jakob
    C. Kollmannsberger
    L. Kanz
    C. Bokemeyer
    Der Urologe, 1998, 37 : 635 - 647